MEDDIC and BANT are two widely used sales qualification frameworks that help B2B teams decide which deals to pursue. BANT focuses on four criteria: Budget, Authority, Need, and Timeline. MEDDIC evaluates six dimensions: Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain, and Champion.
For Indian B2B sales teams selling complex solutions with deal values above INR 10 lakh, MEDDIC consistently outperforms BANT in predicting deal outcomes. The reason is structural: BANT was designed for transactional sales where the buyer knows what they want. MEDDIC was designed for enterprise sales where the buying process is as important as the buying criteria.
Framework Comparison
Here is a side-by-side comparison of both frameworks across key dimensions relevant to Indian B2B.
| Dimension | BANT | MEDDIC |
|---|---|---|
| Primary focus | Can they buy? | Will they buy? |
| Budget assessment | Binary: yes/no | Quantified: ROI metrics |
| Decision maker | Single authority | Economic buyer + champion |
| Buying process | Not assessed | Mapped in detail |
| Competitive position | Not assessed | Decision criteria alignment |
| Internal advocacy | Not assessed | Champion identification |
| Complexity fit | Simple, transactional | Complex, consultative |
| Time to qualify | 10-15 minutes | 2-3 conversations |
Where BANT Falls Short in Indian Enterprise Sales
BANT was created by IBM in the 1960s for a world where a single executive made purchasing decisions. Modern Indian B2B buying involves 5-10 stakeholders, complex approval workflows, and evaluation criteria that evolve during the sales process.
Three specific gaps:
-
Budget is not binary - In Indian enterprises, budget can be created, reallocated, or approved at multiple levels. "Do you have budget?" gets a misleading answer. MEDDIC's approach of quantifying business impact and building an ROI case is more effective because it helps the champion justify budget internally.
-
Authority is distributed - Indian organisations rarely have a single decision-maker for significant purchases. MEDDIC distinguishes between the economic buyer who controls budget and the champion who drives the decision internally. Both are needed.
-
Process is invisible - BANT does not assess the buying process. In Indian enterprise sales, where procurement, legal, and compliance add 3-6 weeks to any deal, understanding the process is essential for accurate forecasting.
Where BANT Still Works
BANT remains effective for specific scenarios:
- SMB sales under INR 5 lakh where one person makes the decision
- Renewal or repeat purchases where the process is already known
- Inbound leads where the buyer has already self-qualified on need and timing
- High-volume, low-complexity sales where speed of qualification matters more than depth
If your average deal cycle is under 30 days and involves fewer than three stakeholders, BANT is sufficient and faster to apply.
MEDDIC in Practice for Indian B2B
Here is how each MEDDIC element maps to Indian B2B sales reality.
Metrics
Quantify the business impact in terms the economic buyer cares about. Indian B2B buyers respond well to metrics framed in productivity gains and cost savings rather than abstract ROI percentages. "This reduces your team's reporting time from 8 hours to 2 hours per week" is more compelling than "this delivers 4x ROI."
Economic Buyer
Identify who controls the budget. In Indian enterprises, this is often one level above where you are selling. If you are talking to a VP, the economic buyer may be the CTO or CEO. You do not need direct access initially, but you need to know who they are.
Decision Criteria and Decision Process
These two elements are where MEDDIC adds the most value over BANT. Map the evaluation criteria and the approval process early. In Indian enterprises, the decision process often includes an informal consensus phase before the formal approval. Understanding this saves weeks of cycle time.
Identify Pain
Not just "do they have a need" but "how acute is the pain and who feels it?" Indian B2B deals accelerate when the pain is felt at the executive level, not just the operational level. If only end-users feel the pain, the deal will stall at budget approval.
Champion
The champion is your internal advocate. In Indian business culture, the champion needs both organisational authority and personal motivation to drive the deal. A champion who likes your product but lacks influence is not a real champion. Mevak's meeting intelligence can help identify champion strength by analysing how they speak about your solution to their colleagues in multi-stakeholder meetings.
Performance Data
A 2025 comparison across 3,000 Indian B2B deals showed measurable differences:
| Metric | BANT-Qualified Deals | MEDDIC-Qualified Deals |
|---|---|---|
| Win rate | 18% | 28% |
| Forecast accuracy | 55% | 72% |
| Average cycle length | 95 days | 82 days |
| Deal value at close vs initial | -12% (discounting) | +8% (value selling) |
MEDDIC-qualified deals close faster because the buying process is mapped early, eliminating surprises in later stages.
Choosing the Right Framework
The choice is not binary. Many Indian B2B teams use both: BANT for initial lead screening and MEDDIC for deals that pass initial qualification. This hybrid approach captures the speed of BANT for high-volume inbound while applying MEDDIC's depth for complex opportunities.
The key is matching framework complexity to deal complexity. Using MEDDIC on a INR 2 lakh SMB deal is overkill. Using BANT on a INR 50 lakh enterprise deal leaves too many blind spots.